Scholarlink

Background <p>Although systemic inflammatory response syndrome (SIRS) is associated with the progression of cirrhosis, its clinical significance in patients with cirrhosis and hepatic encephalopathy (HE) remains unclear.</p> Methods <p>Here, clinical data of 161 hospitalized patients with cirrhosis and HE were analyzed.</p> Results <p>Of these patients, 60 (37.3%) developed SIRS and 40 (24.8%) died during hospitalization. Risk factors for death during hospitalization on univariate Cox analysis were as follows: a model for end-stage liver disease (MELD) score &gt; 18; SIRS; serum C-reactive protein (CRP) &gt; 10&#xa0;mg/L; white blood cells (WBC), neutrophils (NEU), neutrophils/lymphocyte ratios (NLR), serum total bilirubin (TBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST); creatinine (Cr); international normalized ratio (INR). SIRS and a MELD score &gt; 18, were significant independent risk factors (hazard ratio 4.758, 2.539; 95% confidence interval 2.115–10.703, 1.210–5.331; <i>P</i> &lt; 0.001, <i>P</i> &lt; 0.05, respectively). The 28-day survival rates were 95.8%, 89.6%, 61.1%, 37.5%, and 12.5% for SIRS scores of 0, 1, 2, 3, and 4, respectively (<i>P</i> &lt; 0.001). Among patients with a MELD score ≤ 18, mortality was 7% in those without SIRS and 30% in those with SIRS. When a MELD score &gt; 18, mortality was 16% in patients without SIRS and 62% in those with SIRS (<i>P</i> &lt; 0.001). Among uninfected patients, mortality was 4% in those without SIRS and 43% in those with SIRS. Among infected patients the mortality rate was 19% in those who did not meet SIRS diagnostic criteria and 53% among those who met them (<i>P</i> &lt; 0.001).</p> Conclusions <p>This study found that SIRS is a common independent risk factor for death among patients with liver cirrhosis hospitalized for HE. Early identification and treatment of SIRS is essential for improving survival in this patient population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Correlation between systemic inflammatory response syndrome and prognosis of patients with cirrhosis and hepatic encephalopathy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月28日

查看全文
  • Kaiyue Zhang,
  • Ziqun Qu,
  • Rongyu Tang,
  • Hongliang Dong,
  • Jing Fan,
  • Wei Ye

摘要

Background

Although systemic inflammatory response syndrome (SIRS) is associated with the progression of cirrhosis, its clinical significance in patients with cirrhosis and hepatic encephalopathy (HE) remains unclear.

Methods

Here, clinical data of 161 hospitalized patients with cirrhosis and HE were analyzed.

Results

Of these patients, 60 (37.3%) developed SIRS and 40 (24.8%) died during hospitalization. Risk factors for death during hospitalization on univariate Cox analysis were as follows: a model for end-stage liver disease (MELD) score > 18; SIRS; serum C-reactive protein (CRP) > 10 mg/L; white blood cells (WBC), neutrophils (NEU), neutrophils/lymphocyte ratios (NLR), serum total bilirubin (TBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST); creatinine (Cr); international normalized ratio (INR). SIRS and a MELD score > 18, were significant independent risk factors (hazard ratio 4.758, 2.539; 95% confidence interval 2.115–10.703, 1.210–5.331; P < 0.001, P < 0.05, respectively). The 28-day survival rates were 95.8%, 89.6%, 61.1%, 37.5%, and 12.5% for SIRS scores of 0, 1, 2, 3, and 4, respectively (P < 0.001). Among patients with a MELD score ≤ 18, mortality was 7% in those without SIRS and 30% in those with SIRS. When a MELD score > 18, mortality was 16% in patients without SIRS and 62% in those with SIRS (P < 0.001). Among uninfected patients, mortality was 4% in those without SIRS and 43% in those with SIRS. Among infected patients the mortality rate was 19% in those who did not meet SIRS diagnostic criteria and 53% among those who met them (P < 0.001).

Conclusions

This study found that SIRS is a common independent risk factor for death among patients with liver cirrhosis hospitalized for HE. Early identification and treatment of SIRS is essential for improving survival in this patient population.